Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368(9547): 1575-80. PubMed | Google Scholar

Dunlap NE, Bass J, Fujiwara P, Hopewell P, Horsburgh CR, Salfinger M, Simone PM. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2000; 161(4 Pt 1): 1376-1395. PubMed

Rienthong S, Boonin C, Chaiyasirinrote B, Satproedprai N, Mahasirimongkol S, Yoshida H, Kondo Y, Namwat C, Rienthong D. Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand. int J tuberc lung dis. 2015; 19(7): 817-822. PubMed | Google Scholar

Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010; 10(9): 621-29. PubMed | Google Scholar

Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens. Journal of clinical microbiology. 2011; 49(12): 4138-4141. PubMed | Google Scholar

Deun A, Martin A, Palomino JC. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. int J tuberc lung dis. 2010; 14(2): 131-140. PubMed | Google Scholar

Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirilloa DM. Diagnostic Performance of the New Version (v20) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study. Journal of Clinical Microbiology. 2015 Sep; 53(9): 2961-9. PubMed | Google Scholar

World Health Organization. Policy guidance on drug-susceptibility testing (DST) of second-line anti-tuberculosis drugs. WHO. 2008. Google Scholar

Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, Tu S. Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, China. Journal of Clinical Microbiology. 2012; 50(7): 2404-2413. PubMed | Google Scholar

Hain Lifescience GmbH. GenoType MTBDRsl: instruction manual. Hain Life science GmbH, Nehren Germany. 2009.

Magdorf K, Ertel M, Grassot A, Wahn U. Tuberculin conversion and abnormal chest radiograph in an infant. Eur Respir J. 1996; 9(8): 1763-1765. PubMed | Google Scholar

Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C, Adult AIDS Clinical Trials Group A5255 Study Team. Evaluation of Two Line Probe Assays for Rapid Detection of Mycobacterium tuberculosis, Tuberculosis (TB) Drug Resistance and Non-TB Mycobacteria in HIV-Infected Individuals with Suspected TB. Journal of Clinical Microbiology. 2014; 52(4): 1052-1059. PubMed | Google Scholar

Kontsevaya I, Ignatyeva O, Nikolayevskyy V, Balabanova Y, Kovalyov A, Kritsky A, Matskevich O, Drobniewskib F. Diagnostic Accuracy of the GenoType MTBDRsl Assay for Rapid Diagnosis of Extensively Drug-Resistant Tuberculosis in HIV Coinfected Patients. Journal of Clinical Microbiology. 2013; 51(1): 243-248. PubMed | Google Scholar

Lacoma A, García-Sierra N, Prat C, Maldonado J, Ruiz-Manzano HL, Gavin P, Samper S, Ausina V, Domíngueza J. GenoType MTBDRsl for Molecular Detection of Second-Line-Drug and Ethambutol Resistance in Mycobacterium tuberculosis Strains and Clinical Samples. J Clin Microbiol. 2012; 50(1): 30-36. PubMed | Google Scholar

Ajbani K, Nikam C, Kazi M, Gray C, Boehme C, Balan K, Shetty A, Rodrigues C. Evaluation of Genotype MTBDRsl Assay to Detect Drug Resistance Associated with Fluoroquinolones, Aminoglycosides and Ethambutol on Clinical Sediments. PLOS ONE. 2012; 7(11) e49433. PubMed | Google Scholar

Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. Evaluation of the GenoType MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2012; 16(1): 104-9. PubMed | Google Scholar

World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO. 2011.

Dalton T, Cegielski P, Akksilp S, Asencios L, Caoili JC, Cho S, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H, the Global PETTS Investigators. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet. 2012 Oct 20; 380(9851): 1406-17. PubMed | Google Scholar

Kiet VS, Lan NTN, An DD, Dung NH, Hoa DV, Chau NV, Chinh NT, Farrar J, Caws M. Evaluation of the MTBDRsl Test for Detection of Second-Line-Drug Resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology. 2010; 48(8): 2934-2939. PubMed | Google Scholar